| Treatment of Pediatric Anxiety Disorders by Predicting Treatment Response Through Biocellular Markers and Sleep (NCT02189213) | New York State Psychiatric Institute | 2014-07-01 |
| Transcranial Magnetic Stimulation Treatment for Generalized Anxiety Disorder (NCT01815099) | Hartford Hospital | 2014-05-01 |
| Psychotherapy for Anxiety in Children With Autism Spectrum Disorder (NCT02028247) | University of South Florida | 2014-04-01 |
| Brief Behavioral Treatment for Anxiety in Young Children (NCT02051192) | University of South Florida | 2014-01-01 |
| GATE: Generalized Anxiety - A Treatment Evaluation (NCT01912287) | NYU Langone Health | 2013-12-01 |
| Web-based Attention Bias Modification Treatment for Childhood Anxiety Disorders (NCT03764644) | Erasmus Medical Center | 2013-10-01 |
| Attention Bias Modification Treatment for Anxious Youth (NCT01979263) | Weill Medical College of Cornell University | 2013-10-01 |
| The Effects of Emotional Exposure on State Anxiety (NCT03458702) | Texas Tech University | 2013-09-12 |
| Testing Beliefs About Uncertainty in the Treatment of Generalized Anxiety Disorder (NCT01958788) | Concordia University, Montreal | 2013-09-01 |
| Exposure-Focused Family-Based CBT for Youth With ASD and Comorbid Anxiety (NCT01919970) | University of South Florida | 2013-08-01 |
| Attention Retraining for Anxiety Disorder Patients Resistent to Antidepressants (NCT01906268) | Hospital de Clinicas de Porto Alegre | 2013-07-01 |
| Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder (NCT01844115) | Forest Laboratories | 2013-04-30 |
| An Open Label Study of Clinical Utility and Patient Outcomes of the Genecept Assay (NCT01507155) | Genomind, LLC | 2013-04-01 |
| Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder (NCT01766401) | Forest Laboratories | 2013-01-31 |
| Efficacy of SNRI Treatment on Prefrontality in Patients With GAD and Other Comorbities (NCT01975480) | START Clinic for Mood and Anxiety Disorders | 2013-01-01 |
| Calmer Life: Testing the Effectiveness of a Treatment for Anxiety (NCT01702220) | Baylor College of Medicine | 2012-10-01 |
| Cognitive-Behavioral Treatment and Interpretation Modification Training for Adults With Generalized Anxiety Disorder (NCT01681329) | Concordia University, Montreal | 2012-09-01 |
| Locating Regions of Interest in Generalized Anxiety Disorder Using Function Magnetic Resonance Imaging (fMRI) (NCT01607710) | Hartford Hospital | 2012-07-01 |
| Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder (NCT01629966) | Forest Laboratories | 2012-06-30 |
| Transcranial Magnetic Stimulation Treatment for Generalized Anxiety Disorder (NCT01659736) | Hartford Hospital | 2012-05-01 |
| Online Treatments for Mood and Anxiety Disorders in Primary Care (NCT01482806) | University of Pittsburgh | 2012-02-01 |
| Computer- Assisted Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum Disorders (NCT01565629) | University of South Florida | 2012-02-01 |
| Tandospirone Citrate in the Treatment of Patients With Generalized Anxiety Disorder (NCT01614041) | Marubeni Pharmaceuticals (Suzhou) Co., Ltd. | 2012-01-10 |
| Motivational Interviewing and Cognitive Behavioural Therapy for Generalized Anxiety Disorder (NCT01488799) | York University | 2012-01-01 |
| Internet-based Treatment of Generalized Anxiety Disorder (NCT01570374) | Umeå University | 2012-01-01 |
| Treatment Study for Rural Latino Youth With Anxiety (NCT01491880) | University of California, San Diego | 2011-11-01 |
| Computerized Cognitive Behavioral Therapy for Childhood Anxiety in Community Health Centers (NCT01416805) | University of South Florida | 2011-08-01 |
| Combination of Active or Placebo Attentional Bias Modification Treatment (ABMT) to Either Cognitive Behavioral Group Therapy (CBGT) or Psychoeducational Control Intervention (PCI) for Anxiety Disorders in Children (NCT01687764) | Hospital de Clinicas de Porto Alegre | 2011-08-01 |
| Cognitive Behavioral Therapy for Anxiety Disorders in Adolescents With Autism (NCT01563003) | University of South Florida | 2011-06-01 |
| A Clinical Trial to Study the Effects of Sensoril® for Patients With Generalized Anxiety Disorder (NCT01311180) | Natreon, Inc. | 2011-03-01 |
| Electronic Self-management Resource Training for Mental Health (NCT01304862) | Case Western Reserve University | 2011-02-01 |
| Telephone Psychotherapy for Late-Life Generalized Anxiety Disorder (GAD) (NCT01259596) | Wake Forest University Health Sciences | 2011-01-01 |
| A Study of Duloxetine in Elderly Generalized Anxiety Disorder (NCT01118780) | Eli Lilly and Company | 2010-10-01 |
| PHARMO Institute Seroquel Safety Study (NCT01342120) | AstraZeneca | 2010-09-01 |
| Efficacy of Massage Therapy in the Treatment of Generalized Anxiety Disorder (GAD) (NCT01337713) | Emory University | 2010-09-01 |
| Brain Markers of Anxiety Disorders and SSRI/CBT Treatment in Children and Adolescents (NCT01160588) | University of Michigan | 2010-07-01 |
| False Safety Behavior Elimination Therapy: A Randomized Study of a Brief Individual Transdiagnostic Treatment for Anxiety Disorders (NCT02082561) | Florida State University | 2010-07-01 |
| Stress Reduction and Anxiety: Effects on the Function and Structure of the Brain (NCT01128309) | Massachusetts General Hospital | 2010-05-01 |
| Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD) (NCT01172652) | VA Palo Alto Health Care System | 2010-04-01 |
| Generalized Anxiety and Seroquel (NCT01066143) | Mclean Hospital | 2010-02-01 |
| Long Term Chamomile Therapy for Anxiety (NCT01072344) | University of Pennsylvania | 2010-02-01 |
| Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals (NCT01075672) | Massachusetts General Hospital | 2010-01-01 |
| An Open Label Trial of Duloxetine in the Treatment of Irritable Bowel Syndrome and Comorbid Generalized Anxiety Disorder (NCT00961298) | West Penn Allegheny Health System | 2009-09-01 |
| Cognitive Behavioral Therapy (CBT) for Latinos With Generalized Anxiety Disorder in the General Medical Sector (NCT01203293) | University of Puerto Rico | 2009-09-01 |
| Mechanisms of Sleep Disturbance in Children With Generalized Anxiety Disorder (GAD) (NCT01032473) | Children's National Research Institute | 2009-08-01 |
| Exercise Training for the Treatment of Generalized Anxiety Disorder (NCT00953654) | University of Georgia | 2009-08-01 |
| Comparing Different CBT Approaches in GAD (NCT03650465) | Babes-Bolyai University | 2009-05-16 |
| Safety and Efficacy Evaluation Of Pregabalin (Lyrica) With Patients With Generalized Anxiety Disorder (NCT00624780) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2009-05-01 |
| Escitalopram in Patients With Generalized Anxiety Disorder (NCT00902564) | H. Lundbeck A/S | 2009-03-01 |
| Sleep, Mood, and Behavior Study (NCT00787397) | University of Pittsburgh | 2009-02-01 |
| Psychodynamic Internet Treatment Versus Cognitive Behavioral Therapy (CBT) for Generalized Anxiety Disorder (NCT01312116) | Linkoeping University | 2009-01-01 |
| 6-Month Open-Label Safety Study Of PD 0332334 In Elderly Patients With Generalized Anxiety Disorder (GAD) (NCT00738738) | Pfizer | 2009-01-01 |
| Investigation Of How PD 0332334 And Metformin Are Eliminated From The Body When They Are Administered At The Same Time (NCT00809536) | Pfizer | 2009-01-01 |
| Evaluating The Effects Of Cimetidine On The Elimination Of PD 0332334 From The Body (NCT00800280) | Pfizer | 2009-01-01 |
| Duloxetine for the Treatment of Generalized Anxiety Disorder (NCT00803361) | Eli Lilly and Company | 2008-12-01 |
| Relapse-prevention Study With Lu AA21004 (Vortioxetine) in Patients With Generalized Anxiety Disorder (NCT00788034) | H. Lundbeck A/S | 2008-10-01 |
| A 52-Week Open-Label Safety Study of PD 0332334 in Subjects With Generalized Anxiety Disorder (GAD) (NCT00735267) | Pfizer | 2008-10-01 |
| Transdisciplinary Studies of CBT for Anxiety in Youth: Child Anxiety Treatment Study (NCT00774150) | University of Pittsburgh | 2008-10-01 |
| Efficacy and Safety of Vortioxetine (Lu AA21004) for Treatment of Generalized Anxiety Disorder in Adults. (NCT00744627) | Takeda | 2008-09-01 |
| Open-Label Pilot Study to Examine the Value of Substituting Quetiapine for Benzodiazepines (NCT01244711) | Weill Medical College of Cornell University | 2008-09-01 |
| Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months (NCT00711737) | Changi General Hospital | 2008-09-01 |
| Effectiveness of Cognitive Behavioral Therapy (CBT) for Child Anxiety Disorders in Community Clinics in Norway (NCT00735995) | Regionsenter for barn og unges psykiske helse | 2008-08-01 |
| Study of Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder (NCT00731120) | Takeda | 2008-06-01 |
| Efficacy of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder (NCT00730691) | Takeda | 2008-06-01 |
| Quetiapine Extended Release (XR) Treatment of Major Depressive Disorder With Comorbid Generalized Anxiety Disorder (NCT00868374) | Keming Gao | 2008-06-01 |
| Quetiapine in Co-Morbid Depressive and Anxiety Disorders (NCT00688818) | Centre for Addiction and Mental Health | 2008-06-01 |
| An Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder (NCT00734071) | Takeda | 2008-06-01 |
| A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder (3) (NCT00658762) | Pfizer | 2008-05-01 |
| Cognitive Behavior Treatment of Older Adults With Generalized Anxiety Disorder in Primary Care (NCT00765219) | Baylor College of Medicine | 2008-05-01 |
| A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (2) (NCT00658372) | Pfizer | 2008-05-01 |
| Drug Treatment Validation of Functional Magnetic Resonance Imaging in Generalized Anxiety Disorder (NCT00662259) | University of California, San Diego | 2008-04-01 |
| A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (1) (NCT00658008) | Pfizer | 2008-04-01 |
| Stress Reduction Techniques and Anxiety: Therapeutic and Neuroendocrine Effects (NCT01033851) | Massachusetts General Hospital | 2008-03-01 |
| Exploratory Study to Evaluate the Effect of SYN111 (Rufinamide) in Patients With Generalized Anxiety Disorder (GAD) (NCT00595231) | Biotie Therapies Inc. | 2008-03-01 |
| Virtual Reality as Anxiety Management Tool for Generalized Anxiety Disorder (NCT00602212) | Istituto Auxologico Italiano | 2008-02-01 |
| rTMS Treatment in Patients With General Anxiety Disorder (NCT00616447) | Queen's University | 2008-01-01 |
| Anxiety in Recovering Opiate Dependence (NCT00668265) | Beth Israel Medical Center | 2008-01-01 |
| Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects (NCT00616655) | Sumitomo Pharma America, Inc. | 2008-01-01 |
| Attention Training for Generalized Anxiety Disorder (NCT00602563) | San Diego State University | 2007-12-01 |
| ERP N1 as a Treatment Predictor of Generalized Anxiety Disorder (NCT00613067) | Inje University | 2007-12-01 |
| Antidepressant Treatment Plus Cognitive Behavioral Therapy for Generalized Anxiety Disorder in Older Adults (NCT00601965) | Veterans Medical Research Foundation | 2007-10-01 |
| Neural Functioning Underlying Anxiety and Its Treatment (The INSULA Study) (NCT00947570) | University of California, San Diego | 2007-10-01 |
| An Open-label Study to Investigate the Absorption, Metabolism and Excretion of Radiolabeled PD 0332334 in Six Healthy Male Volunteers (NCT00537615) | Pfizer | 2007-09-01 |
| Therapeutic Massage for Generalized Anxiety Disorder (NCT00515242) | Kaiser Permanente | 2007-09-01 |
| Evaluating the Effects of Stress in Pregnancy (NCT00525226) | Emory University | 2007-09-01 |
| Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and/or GAD (NCT00579280) | University of South Florida | 2007-07-01 |
| Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder (NCT00481325) | Bristol-Myers Squibb | 2007-07-01 |
| Brain Imaging and Computer Games in Children With Either Bipolar Disorder, ADHD, Anxiety or Healthy Controls (NCT01570426) | Bradley Hospital | 2007-07-01 |
| CBT for GAD: Impact of Cognitive Processing on Treatment Outcome (NCT03099772) | Concordia University, Montreal | 2007-04-01 |
| RCT of an Acceptance-based Behavior Therapy for GAD (NCT00961493) | University of Massachusetts, Boston | 2007-03-01 |
| Comparing Cognitive Behaviour Therapy (CBT) With Metacognitive Therapy (MCT) in the Treatment of GAD (NCT00426426) | Norwegian University of Science and Technology | 2007-01-01 |
| Pregabalin in the Treatment of Patients With Generalized Anxiety Disorder (GAD). (NCT00413010) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2006-12-01 |
| Combined Treatment for Generalized Anxiety Disorder (GAD) (NCT00620776) | University of Pennsylvania | 2006-10-01 |
| Efficacy and Safety of Pregabalin vs Placebo for Generalized Anxiety Disorder (GAD) Symptoms in Subjects Discontinuing Benzodiazepine Treatment and Remaining 6 Weeks on Study Medication, Free From Benzodiazepine Use. (NCT00368745) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2006-09-01 |
| Repetitive Magnetic Transcranial Stimulation (rTMS) in the Treatment of Generalized Anxiety Disorder (GAD) (NCT00662584) | University of California, Los Angeles | 2006-08-01 |
| Efficacy of Treatment for Generalized Anxiety Disorder (NCT00456742) | University of British Columbia | 2006-06-01 |
| Primary Care Intervention Strategy for Anxiety Disorders (NCT00347269) | University of Washington | 2006-06-01 |
| Efficacy and Safety Study of Seroquel SR in the Treatment of Generalized Anxiety Disorder (NCT00322595) | AstraZeneca | 2006-05-01 |
| Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo & Active Control in Generalized Anxiety Disorder (NCT00329446) | AstraZeneca | 2006-04-01 |
| Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety Disorder (NCT00329264) | AstraZeneca | 2006-04-01 |